Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001437749-22-021367

Pres. Diagnostics & Genom acquired 663 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Pres. Diagnostics & Genom 2022-08-23 Option exercise +663 $150.78 $99,967 3,801 D
Derivatives
Kelderman Kim Pres. Diagnostics & Genom 2022-08-23 Option exercise · Stock Option (Right to Buy) −663 6,848 D
Loading xslF345X03/rdgdoc.xml…